MBX Biosciences, Inc. ($MBX)
Filing Information
| Accession Number | 0001193125-26-331642 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 4, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
158,000
Total Value
$0.00
P&L
+inf% (+$10,661,840.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Aug 3, 2026 | Grant/Award | 28,000 | $0.00 | $0.00 | 28,000 | Direct | โ | View Details | |
Chief Financial Officer | Stock option (right to buy) | Derivative | Aug 3, 2026 | Grant/Award | 130,000 | $0.00 | $0.00 | 130,000 | Direct | โ | View Details |